Hallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in senescence-accelerated mice

Experimental Animals

Volumn 59, Issue 4, 2010, Pages 441-447

  Niimi, Kimie ^a,b   Takahashi, Eiki ^b   Itakura, Chitoshi ^b  

^a Brain Science And Life Technology Research Foundation   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

DOI; SAM; Signaling pathway

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; AMPHETAMINE DERIVATIVE; CREBBP PROTEIN, MOUSE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; PSYCHEDELIC AGENT; SEROTONIN 2 AGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONCENTRATION PROCESS; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HEAD TWITCH; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SENESCENCE ACCELERATED MOUSE; SIGNAL TRANSDUCTION; SOMATOSENSORY CORTEX; STRAIN DIFFERENCE; WESTERN BLOTTING; AGING; ANIMAL; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; HEAD MOVEMENT; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PREMATURE AGING;

MUS;

AGING; AGING, PREMATURE; AMPHETAMINES; ANIMALS; BEHAVIOR, ANIMAL; CREB-BINDING PROTEIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HALLUCINOGENS; HEAD MOVEMENTS; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; PHOSPHORYLATION; SEROTONIN 5-HT2 RECEPTOR AGONISTS; SIGNAL TRANSDUCTION; SOMATOSENSORY CORTEX;

EID: 77957242575     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.59.441     Document Type: Article

References (24)

1. Allen, J.A., Yadav, P.N., and Roth, B.L. 2008. Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases. Neuropharmacology 55: 961-968.
2. Berg, K.A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., and Clarke, W.P. 1998. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol. Pharmacol. 54: 94-104.
3. Chalecka-Franaszek, E., Chen, H., and Chuang, D.M. 1999. 5-Hydroxytryptamine2A receptor stimulation induces activator protein-1 and cyclic AMP-responsive element binding with cyclic AMP-responsive element-binding protein and Jun d as common components in cerebellar neurons. Neuroscience 88: 885-898.
4. Conn, P.J., Christopoulos, A., and Lindsley, C.W. 2009. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat. Rev. Drug Discov. 8: 41-54.
5. Gelber, E.I., Kroeze, W.K., Willins, D.L., Gray, J.A., Sinar, C.A., Hyde, E.G., Gurevich, V., Benovic, J., and Roth, B.L. 1999. Structure and function of the third intracellular loop of the 5-hydroxytryptamine2A receptor: the third intracellular loop is alpha-helical and binds purified arrestins. J. Neurochem. 72: 2206-2214.
6. Glennon, R. 1990. Serotonin receptors: clinical implications. Neurosci. Biobehav. Rev. 14: 35-47.
7. González-Maeso, J., Weisstaub, N.V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., Sealfon, S.C., and Gingrich, J.A. 2007. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53: 439-452.
8. González-Maeso, J., Yuen, T., Ebersole, B.J., Wurmbach, E., Lira, A., Zhou, M., Weisstaub, N., Hen, R., Gingrich, J.A., and Sealfon, S.C. 2003. Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J. Neurosci. 23: 8836-8843.
9. Gray, J.A. and Roth, B.L. 2001. Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists. Brain Res. Bull. 56: 441-451.
10. Gray, J.A., Sheffler, D.J., Bhatnagar, A., Woods, J.A., Hufeisen, S.J., Benovic, J.L., and Roth, B.L. 2001. Cell-type specific effects of endocytosis inhibitors on 5-hy- droxytryptamine (2A) receptor desensitization and resensi-tization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in human embryonic kidney 293 cells. Mol. Pharmacol. 60: 1020-1030.
11. Jordan, J.D., Landau, E.M., and Iyengar, R. 2000. Signaling networks: the origins of cellular multitasking. Cell 103:193-200.
12. Kenakin, T. 1995. Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. Trends Pharmacol. Sci. 16: 232-238.
13. Mayr, B. and Montminy, M. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2: 599-609.
14. Menzaghi, F., Behan, D.P., and Chalmers, D.T. 2002. Constitutively activated G protein-coupled receptors: a novel approach to CNS drug discovery. Curr. Drug Targets CNS Neurol. Disord. 1: 105-121.
15. Newton, R.A., Phipps, S.L., Flanigan, T.P., Newberry, N.R., Carey, J.E., Kumar, C., Mcdonald, B., Chen, C., and Elliott, J.M. 1996. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs. J. Neurochem. 67: 2521-2531.
16. Niimi, K., Takahashi, E., and Itakura, C. 2008. Emotional behavior and expression patterns of tyrosine hydroxylase and tryptophan hydroxylase in senescence-accelerated mouse (SAM) P6 mice. Behav. Brain Res. 188: 329-336.
17. 2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Mol. Brain Res. 23: 163-178.
18. Schmid, C.L., Raehal, K.M., and Bohn, L.M. 2008. Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo. Proc. Natl. Acad. Sci. U.S.A. 105: 1079-1084.
19. Smith, R.L., Barrett, R.J., and Sanders-Bush, E. 1999.Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor. Psychopharmacology 144: 248-254.
20. Takeda, T. 1999. Senescence-accelerated mouse (SAM): a biogerontological resource in aging research. Neurobiol. Aging 20: 105-110.
21. Urban, J.D., Clarke, W.P., von Zastrow, M., Nichols, D.E., Kobilka, B., Weinstein, H., Javitch, J.A., Roth, B.L., Christopoulos, A., Sexton, P.M., Miller, K.J., Spedding, M., and Mailman, R.B. 2007. Functional selectivity and classical concepts of quantitative pharmacology. J. Pharmacol. Exp.Ther, 320; 1-13.
22. Violin, J.D. and Lefkowitz, R.J. 2007. Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol. Sci. 28: 416-422.
23. Willins, D.L. and Meltzer, H.Y. 1997. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J. Pharmacol. Exp. Ther. 282: 699-706.
24. Xing, J., Ginty, D.D., and Greenberg, M.E. 1996. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273: 959-963.